Ignite Creation Date:
2024-05-06 @ 9:58 AM
Last Modification Date:
2024-10-26 @ 12:22 PM
Study NCT ID:
NCT03123016
Status:
COMPLETED
Last Update Posted:
2019-08-28
First Post:
2017-04-11
Brief Title:
Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Icahn School of Medicine at Mount Sinai
Organization Data
Organization:
Icahn School of Medicine at Mount Sinai
Class:
OTHER
Study ID:
GCO 16-1261
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Lead Sponsor Class:
OTHER
Responsible Party:
Mark Lebwohl
Responsible Party Title:
Professor and System Chair
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Icahn School of Medicine at Mount Sinai
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Celgene | INDUSTRY |